13F

Stock

Moleculin Biotech, Inc.

MBRX · held by 17 managers

Reported value

$315.2K

Holders

17

+3 new · −0 exited

Holders’ est. mark

$200

Price effect on 2 books still in the name

Largest holder

$109.5K

Citadel

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Citadel33.1K$109.5KHeld
JANE STREET GROUP, LLC22.6K$74.6KHeld
Vanguard15.5K$51.5KHeld
GEODE CAPITAL MANAGEMENT, LLC15.1K$50.1KHeld
UBS Group AG5.86K$19.4KHeld
Tower Research Capital LLC (TRC)1.39K$4.61KHeld
BlackRock, Inc.495$1.64KHeld
EFG International AG434$1.44KHeld
Pinnacle Wealth Planning Services, Inc.281$930Held
Rockefeller Capital Management L.P.218$722Held
Newbridge Financial Services Group, Inc.114$377Held
MORGAN STANLEY36$119$100Cut−$372
BANK OF AMERICA CORP /DE/36$119$100Cut−$22
SBI Securities Co., Ltd.29$96Held
DANSKE BANK A/S2$7New
OSAIC HOLDINGS, INC.1$3Held
CVA Family Office, LLC1$3Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.